Novel 4'-hydroxymethyl-2',3'-dideoxy-3'-thianucleosides and their cyclic monophosphates have been synthesized and evaluated for anti-HIV activity. This is the first report of the use of the phosphorodiamidite methodology to prepare cyclic nucleoside monophosphates.